Antiviral effects of silymarin against hepatitis C: the jury is still out
Hepatology
.
2008 Jul;48(1):345-6.
doi: 10.1002/hep.22235.
Authors
Stephen J Polyak
,
Chihiro Morishima
,
Roy Hawke
PMID:
18509876
DOI:
10.1002/hep.22235
No abstract available
Publication types
Comment
Letter
MeSH terms
Antiviral Agents / therapeutic use*
Hepatitis C, Chronic / drug therapy*
Humans
Silymarin / therapeutic use*
Substances
Antiviral Agents
Silymarin
Grants and funding
R21 AT002895/AT/NCCIH NIH HHS/United States
R21 AT002895-01A2/AT/NCCIH NIH HHS/United States